SCHEMBL7754110

SCHEMBL7754110

COc1cc2cnc(Nc3ccc(C)c(Br)c3)nc2cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.54
ERBB2 P04626 3/20 0.54
RAD52 P43351 2/20 0.49
TP53 P04637 2/20 0.49
MAPT P10636 2/20 0.49
POLB P06746 1/20 0.49
MEN1 O00255 1/20 0.46
UBE2N P61088 1/20 0.46
KMT2A Q03164 1/20 0.46
KDR P35968 3/20 0.45
ABCG2 Q9UNQ0 3/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SLC2A1 P11166 1/20 0.43
ABCB1 P08183 1/20 0.42
JAK3 P52333 1/20 0.42
BRAF P15056 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1246693 0.86 ABCG2 (0.58) EGFRERBB2RAD52TP53MAPT
SCHEMBL7799220 0.81 ABCG2 (0.65) EGFRERBB2MAPTKDRABCG2
SCHEMBL7797381 0.80 KDM4E (0.43) EGFRERBB2RAD52TP53MAPT
SCHEMBL2205050 0.80 KDM4E (0.52) EGFRERBB2RAD52MAPTMEN1
SCHEMBL8812882 0.79 PDGFRB (0.57) EGFRTP53MAPTPOLBKDR
SCHEMBL7801861 0.79 KDM4E (0.55) EGFRTP53MAPTPOLBKDR
SCHEMBL360021 0.79 EGFR (0.53) EGFRTP53MAPTPOLBKDR
SCHEMBL7757002 0.79 PDGFRB (0.59) EGFRMAPTKDRKDM4EALDH1A1
SCHEMBL27565491 0.78 KDM4E (0.49) RAD52TP53MAPTPOLBMEN1
SCHEMBL7766729 0.78 MEN1 (0.46) EGFRERBB2TP53MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999061428-A9 QUINAZOLINES FOR TREATING BRAIN TUMOR PARKER HUGHES INST (US) 2001-10-04 WO disclosed
WO-2001035952-A2 RADIOSENSITIZATION OF HUMAN GLIOBLASTOMA CELLS BY QUINAZOLINE COMPOUNDS PARKER HUGUES INSTITUTE (US) 2001-05-25 WO disclosed